Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Tale of two approaches to ultrasound-guided interscalene brachial plexus block: a pro-con
Owen, Robert L. , VanderWielen, Beth A. , Johnson, Rebecca L. , Owen, Robert Loren , Johnson, Rebecca L , Amundson, Adam W.

Regional Anesthesia & Pain Medicine | June 24, 2025 | Volume: 51 | Issue: 8 | Pages: 985-988

10.1136/rapm-2025-106624 | PMID 40555526 Get It

The interscalene brachial plexus block is a well-described and widely used peripheral nerve block effective for regional anesthesia and analgesia in orthopedic surgical procedures of the shoulder, upper arm, and clavicle. Conventionally, an in-plane ultrasound-guided approach has been the technique of choice, while the out-of-plane approach, though less described, has been gaining anecdotal momentum among a growing number of proceduralists. This pro-con discussion highlights the out-of-plane approach’s goal of avoiding needle injuries to nerves that course through the middle scalene muscle and the in-plane approach’s benefit of whole-shaft needle visualization and increased distance away from the plexus on entry. We aim to provide a comprehensive comparison to guide proceduralists in their clinical decision-making.
Midclavicle block for midshaft clavicle fractures: an anatomical study
Labandeyra, Hipólito , Sala‐Blanch, Xavier , D’Souza, Ryan S. , Valdés-Vilches, Luis Fernando , Prats‐Galino, Alberto , D'Souza, Ryan S , Sala-Blanch, Xavier

Regional Anesthesia & Pain Medicine | June 24, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106856

10.1136/rapm-2025-106856 | PMID 40555525 Get It

Background The Midclavicle Block achieves balanced methylene blue spread across both anterosuperior and posteroinferior periosteal surfaces in cadavers with intact clavicles. Objective To evaluate the anatomical distribution pattern of the Midclavicle Block in cadaveric specimens with midshaft clavicle fractures, with a focus on periosteal coverage and involvement of the fracture site. Methods An anatomical study was conducted on 10 cadavers (20 clavicular regions). A midshaft clavicle fracture model was created, and the Midclavicle Block technique was applied under ultrasound guidance. A methylene blue solution was injected, and dissections were performed to evaluate dye spread primarily in the deep muscular and the clavicular plane, including the fracture site. Probabilistic maps of dye distribution were generated. Results The anatomical dissection in the deep muscular plane revealed consistent staining of the fracture site in all specimens, along with the subclavius muscle and the clavipectoral fascia, while the pectoralis minor muscle remained unaffected in every case. As the dissection progressed toward the infraclavicular brachial plexus plane, no staining of the plexus was observed, with dye spread restricted to the subclavius muscle and adjacent clavipectoral fascia. The mean staining of the anterosuperior and posteroinferior periosteal surfaces was 55.5% (95% CI: 50.6% to 60.4%) and 53.8% (95% CI: 49.5% to 58.1%), respectively. The highest dye concentration was observed in the middle third of the clavicle, corresponding to the fracture zone. Conclusion The Midclavicle Block resulted in effective periosteal coverage and targeted fracture site staining. Clinical studies are needed to confirm its in vivo efficacy, given the limitations inherent to cadaveric specimens.
Case 338: Right Retroperitoneal Lymphatic-Venous Malformation
Shah, Amar , Zulfiqar, Maria , Zulfiqar, Maria , Shah, Amar S

Radiology | June 24, 2025 | Volume: 315 | Issue: 3 | Pages: No page available

10.1148/radiol.242728 | PMID 40553001 Get It

History A 25-year-old female patient presented to the emergency department with worsening abdominal discomfort over the past 2–3 months. The patient had not experienced fever, chills, or dysuria. Past medical history was notable for two completed pregnancies; otherwise, there was no pertinent medical history or family history. At physical examination, the patient was uncomfortable but not in acute distress. There was tenderness to palpation in the right upper quadrant and epigastric region, but no rebound tenderness or guarding. Vital signs were blood pressure of 141/85 mm Hg, pulse rate of 91/min, and temperature of 37.2 °C. The serum β–human chorionic gonadotropin test result was negative for pregnancy, and urinalysis showed no leukocyte esterase or nitrites. Routine blood investigations, including white blood cell count, were within normal limits. Initial evaluation with contrast-enhanced CT of the abdomen and pelvis was performed, followed by MRI of the abdomen without and with intravenous contrast material.
New Diagnosis of Granulomatosis With Polyangiitis Presenting With Oral Ulcerations, Ileitis, and Hematochezia
Rolak, Stacey , Pham, Michael M., Lam‐Himlin, Dora , Batheja, Mashal, Lam-Himlin, Dora M, Batheja, Mashal J, Pham, Michael M.

ACG Case Reports Journal | June 24, 2025 | Volume: 12 | Issue: 6 | Pages: e01746

10.14309/crj.0000000000001746 | PMID 40567528 Get It

ABSTRACT Granulomatosis with polyangiitis (GPA) is a rare small vessel vasculitis that commonly presents with multiorgan involvement of the upper airways, lungs, and kidneys. We report a 55 year-old-man who presented with painful oral ulcers, diffuse joint pain, epistaxis, and intermittent maroon bowel movements. Infectious evaluation was unremarkable. Rheumatologic evaluation demonstrated elevated c-anti-neutrophil cytoplasmic antibody and proteinase 3 antibodies. Colonoscopy with terminal ileum biopsies demonstrated angiocentric inflammatory findings supportive of a diagnosis of GPA. This case was unusual in its presentation with predominately oral manifestations. A diagnosis of GPA should remain on the differential for patients with gastrointestinal bleeding, and these systemic symptoms require a high level of suspicion to lead to timely diagnosis.
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice
Borogovac, Azra , Efebera, Yvonne A. , DeSalvo, Anna M. , Foley, Amy , Stewart, Valerie , Hamilton, Betty K. , Heuer, Mykala, Molfenter, Todd , Ragon, Brittany Knick , Wall, Sarah , Khera, Nandita , Horowitz, Mary M. , DeZern, Amy E., Bhatt, Neel S , DeSalvo, Anna , Hamilton, Betty K , Molfenter, Todd , Wall, Sarah A , Broglie, Larisa A , Juckett, Mark , Bhatt, Neel S. , Devine, Steven M. , Heuer, Mykala, Plastaras, John Peter , Broglie, Larisa , Dezern, Amy Elizabeth

Blood Advances | June 24, 2025 | Volume: 9 | Issue: 17 | Pages: 4448-4457

10.1182/bloodadvances.2024015405 | PMID 40554428 Get It

Abstract Severe aplastic anemia (SAA) is a rare and life-threatening bone marrow failure disorder. Immunosuppressive therapy (IST) with antithymocyte globulin and cyclosporine has long been a frontline treatment option in SAA; however, its limited durability and risk of long-term complications such as secondary malignancies remain a drawback in this treatment modality. Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative option with significantly improved outcomes over the long term, particularly with HLA-matched related donors. However, the use of alternative donors, such as haploidentical, mismatched, or matched unrelated donors, has previously been limited due to increased transplant-related morbidity, particularly graft-versus-host disease (GVHD). HCTs have therefore been limited to young recipients and those with HLA-matched related donors, creating significant disparity for older adults and those who lack matched donor options. Nevertheless, more recent advances in HCT, such as posttransplant cyclophosphamide for GVHD prophylaxis, have led to improved outcomes of HCT with alternative donors; however, alternative donor HCT remains underused as up-front therapy, in part because of limited multicenter trial data. This review discusses current SAA treatment approaches, including both IST and HCT, and highlights remaining gaps. It also discusses how ongoing clinical trials such as CureAA and TransIT could help address these gaps. Furthermore, we discuss the importance of stakeholder engagement and implementation science in the integration of research-based evidence into clinical practice. Bridging these gaps is necessary for achieving equitable access for patients historically excluded from frontline HCT, including older adults and racially or ethnically diverse populations.
Interaction of cardiomyocytes from CCND2-overexpressing human induced pluripotent stem cells with electrically conductive hydrogels
Jang, Michelle, Son, Yura , Patino-Guerrero, Alejandra , Singh, Yamini , Neff, Keagan, Zhu, Wuqiang , Zhu, Wuqiang , Neff, Keagan, Nikkhah, Mehdi

RSC Advances | June 24, 2025 | Volume: 15 | Issue: 27 | Pages: 21408-21423

10.1039/d5ra03024b | PMID 40556703 Get It

Biomaterials like gold nanorod-embedded gelatin methacrylate (GelMA-GNR) hydrogels support the delivery of regenerative cells such as human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), enhancing EHT performance.
A Novel Testing Battery for Preserved Autonomic Regulation Following Spinal Cord Injury and New Translationally Focused Data Representation
Burns, Kathryn , Veith, Daniel D. , Solinsky, Ryan , Hamner, Jason W. , Singer, Wolfgang , Taylor, J. Andrew

Topics in Spinal Cord Injury Rehabilitation | June 24, 2025 | Volume: 31 | Issue: 2 | Pages: 50-61

10.46292/sci24-00071 | PMID 40585014 Get It

Background: Autonomic dysfunction is common after spinal cord injury (SCI). There are currently limited tools to comprehensively characterize its deficits. While individual established autonomic tests have a long history and sound scientific background, translating these autonomic testing results to inform clinical understanding is a major barrier. Objectives: To assess a strategic battery of autonomic tests to characterize and act as a biomarker of autonomic regulation for individuals with SCI and to develop a novel graphical representation of these data to facilitate understanding of autonomic dysfunction after SCI. Methods: We outline a battery of six laboratory autonomic tests that were curated to collectively describe the ability of individuals with SCI to inhibit and recruit sympathetic activity through the injured spinal cord. Heart rate/blood pressure variability, bolus phenylephrine, hand and foot cold pressor, Valsalva maneuver, and bladder pressor are herein described. Incorporating normative control data for 30 uninjured individuals completing this testing battery, we further demonstrate the utility of a composite biomarker, comparing these control results to 11 individuals with SCI. Results: Results demonstrate strong normality of data with testing psychometrics, suggesting stable reproducibility with repeat testing. Even in this preliminary sample of individuals with SCI, clear differences begin to emerge compared to uninjured norms. This illustrates the ability of this collective testing battery to characterize autonomic regulation after SCI. To aid in clinical translation, we further present a graphical representation, an autonomic phenotype , which serves as a snapshot of how normal or abnormal sympathetic inhibition and recruitment of activation may be after SCI. Conclusion: Utilizing these autonomic phenotypes, three example cases of individuals with SCI highlight evidence of varied degrees of autonomically complete SCI. Together, this represents a key advancement in our understanding of autonomic function after SCI.
Association between Exposure to Statin Choice and Adherence to Statins: An Observational Cohort Study
Martinez, Kathryn A. , Montori, Víctor M. , Rodríguez, Fátima , Tereshchenko, Larisa G. , Kovach, Jeffrey D. , Hurwitz, H. , Montori, Victor M , Martinez, Kathryn , Boyer, Christopher , Rothberg, Michael B.

Medical Decision Making | June 24, 2025 | Volume: 45 | Issue: 7 | Pages: 884-891

10.1177/0272989x251346508 | PMID 40553465 Get It

Background Statin Choice is a shared decision-making encounter tool embedded in the electronic health record. Objective To describe the association between the use of Statin Choice, statin prescriptions by clinicians, prescription fills (primary adherence), and statin adherence at 12 mo (secondary adherence). Design Observational cohort study at the Cleveland Clinic Health System. Subjects Statin-naïve adults aged 40 to 75 y with a 10-y atherosclerotic cardiovascular disease (ASCVD) risk of ≥5% and a primary care appointment between January 2020 and July 2021. Main Measures The primary exposure was the use of Statin Choice during a clinical encounter. We measured whether the use of Statin Choice was associated with statin prescriptions. We measured statin adherence based on pharmacy fill data at 60 d (primary adherence) and 12 mo (secondary adherence). We used mixed-effects logistic regression to estimate the adjusted odds of statin prescriptions and adherence at the 3 time points by the use of Statin Choice. Key Results Among 17,001 statin-naïve patients, 13% viewed Statin Choice and 7% were prescribed a statin. The median ASCVD risk was 10%. Patients who were shown Statin Choice had 9.04 higher odds of being prescribed a statin compared with patients not shown Statin Choice (95% confidence interval [CI]: 7.86–10.4). Among patients prescribed a statin, the use of Statin Choice was associated with 5.75 higher odds of primary adherence compared with usual care (95% CI: 4.22–7.83). At 12 mo, Statin Choice use was significantly associated with adherence in the unadjusted analysis (OR: 1.58; 95% CI: 1.05–2.08) but was not significant after adjustment for patient factors. Patients shown Statin Choice had an average of 12 mg/dL reduction in low-density lipoprotein cholesterol at 12 mo (95% CI: −16 mg/dL, −10) compared with those not shown Statin Choice. Conclusion In this observational study, Statin Choice use was strongly associated with statin prescription and fills and weakly associated with adherence to statins for up to 1 y. A randomized trial is needed to confirm causality. Highlights Statin Choice is an electronic health record–embedded shared decision-making encounter tool available for free in many health care systems. Small randomized controlled trials have found modest associations between the use of Statin Choice and statin adherence using patient-reported data. In our large study using pharmacy fill data, clinician use of Statin Choice during a medical encounter was associated with significantly greater patient adherence with statins up to 1 y later. Exposure to Statin Choice was associated with a significant reduction in low-density lipoprotein cholesterol over 1 y.
Reply to Hu et al. and Tenan and Nimphius
Joyner, Michael J. , Hunter, Sandra K. , Senefeld, Jonathon W. , Hunter, Sandra K , Joyner, Michael J , Senefeld, Jonathon W

Journal of Applied Physiology | June 24, 2025 | Volume: 139 | Issue: 1 | Pages: 103-104

10.1152/japplphysiol.00403.2025 | PMID 40553447 Get It

Perivascular Tertiary Lymphoid Structures in Autoimmune Disease
Goronzy, Jörg J. , Weyand, Cornelia M. , Goronzy, Jorg

Immunological Reviews | June 24, 2025 | Volume: 332 | Issue: 1 | Pages: No page available

10.1111/imr.70047 | PMID 40553008 Get It

ABSTRACTImmunotherapy of autoimmune diseases has expanded substantially, yet autoimmunity remains incurable, and patients suffer from chronic destructive tissue inflammation that fails to resolve. Mechanisms underlying the endurance of autoimmune memory and the lack of exhaustion are beginning to be understood. Here, we review emerging data on how decentralization of cellular immunity contributes to persistent autoimmune responses and chronicity of autoimmune tissue inflammation. Two processes are recognized as ensuring lasting immune memory: the generation of tissue‐resident memory T cells (TRM) and the formation of tertiary lymphoid structures (TLS). TLS, lymphoid aggregates formed outside of lymphoid organs, develop under conditions of chronic immune stimulation, such as autoimmune disease, anti‐tumor immunity, and during immune aging. TLS display heterogeneity in structure and cellular composition that may determine whether they ultimately serve as protective or pathogenic elements. Recent data have implicated TLS as a critical resource in upholding autoimmune responses, emphasizing their role in harming the host. In patients with autoimmune vasculitis, adventitial TLS drives protracted autoimmune disease by housing TCF1hi CD4+ T stem cells that escape exhaustion and provide a continuous supply of pathogenic effector T cells to the disease lesions. The local production and stemness of CD4+ T cells bring resilience to autoreactive immunity, defining novel therapeutic targets in the management of autoimmune disease.